
Rebopag contains Eltrombopag 50 mg and is used to treat low platelet counts in conditions like chronic immune thrombocytopenia (ITP), severe aplastic anemia (SAA), and thrombocytopenia in hepatitis C patients.
| Generic Name | Eltrombopag |
| Manufacturer | MSN Laboratories (India) |
| Packing | 28 Tablets |
| Prescribed For | Chronic Idiopathic Thrombocytopenia |
| Availability | In Stock |
| Shipping to | USA, UK, Australia, Canada, New Zealand, Philippines, Tunisia, France, Italy, South Korea, Albania, Romania, Hong Kong, Malaysia, Thailand, Singapore, Japan, UAE, Saudi Arabia, Qatar, Kuwait, Georgia, Mexico, and many other countries. |




| Package | USD | GBP | AUD | NZD | PHP | KRW | RON | HKD | MYR | THB | AED |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 28 Tablets | $130 | £97 | A$182 | NZ$226 | ₱8,155 | ₩177,819 | lei 597 | HK$1,020 | RM524 | ฿4,323 | د.إ477 |
Eltrombopag prices may vary between countries depending on the brand, dosage form, strength, pack size, pharmacy, insurance coverage, government subsidies, taxes and local healthcare policies. The following resources provide country-specific pricing, reimbursement or medicine information.